{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:29:26Z","timestamp":1769851766517,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1124\/jpet.113.208595","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:26:50Z","timestamp":1379550410000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials"],"prefix":"10.1016","volume":"347","author":[{"given":"E.","family":"van de Steeg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.T.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"van Duyvenvoorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.H.","family":"Offerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Wortelboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"DeGroot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.208595_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3630","article-title":"A decade of change","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.208595_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrd3439","article-title":"Trial watch: Phase II failures: 2008-2010","volume":"10","author":"Arrowsmith","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.208595_bib3","unstructured":"Beth Smith ME, Lee JL, Haney E, Carson S (2009) HMG-CoA reductase inhibitors (statins) and fixed-dose combination products contatining a statin - update 5 (Oregon Health Resources Commission) ."},{"key":"10.1124\/jpet.113.208595_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrd1384","article-title":"Prospects for productivity","volume":"3","author":"Booth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.208595_bib5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1177\/0091270011422815","article-title":"Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2-\/- mice and intraindividual variability in human subjects","volume":"52","author":"DeGorter","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.113.208595_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00005344-200307000-00010","article-title":"Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice","volume":"42","author":"Delsing","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.113.208595_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005344-200501000-00010","article-title":"Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice","volume":"45","author":"Delsing","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.113.208595_bib8","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/mp300108c","article-title":"Organic anion-transporting polypeptides 1a\/1b control the hepatic uptake of pravastatin in mice","volume":"9","author":"Iusuf","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.113.208595_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/156800605774962077","article-title":"HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol","volume":"5","author":"Kleemann","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"10.1124\/jpet.113.208595_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000086460.55494.AF","article-title":"Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin","volume":"108","author":"Kleemann","year":"2003","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.208595_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.208595_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1124\/dmd.105.009076","article-title":"Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism","volume":"34","author":"Lau","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.113.208595_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.113.208595_bib14","unstructured":"Liengme BV (2010) Exceltips: regression analysis confidence interval (http:\/\/people.stfx.ca\/bliengme\/ExcelTips\/RegressionAnalysisConfidence2.htm)."},{"issue":"5A","key":"10.1124\/jpet.113.208595_bib15","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.113.208595_bib16","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.208595_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003088-200847070-00003","article-title":"Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin","volume":"47","author":"Neuvonen","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.113.208595_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.113.208595_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/dmd.30.11.1158","article-title":"Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin","volume":"30","author":"Nezasa","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.113.208595_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.208595_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.208595_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/jps.21533","article-title":"Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice","volume":"98","author":"Peng","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.113.208595_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","article-title":"Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake","volume":"415","author":"Tiwari","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.113.208595_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-2828(02)00284-5","article-title":"Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice","volume":"35","author":"van de Poll","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.113.208595_bib25","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1097\/HJH.0b013e3282ef79f7","article-title":"Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice","volume":"25","author":"van der Hoorn","year":"2007","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.113.208595_bib26","first-page":"396","article-title":"Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs","volume":"48","author":"van Vlijmen","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.113.208595_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117117","article-title":"Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice","volume":"93","author":"van Vlijmen","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.208595_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/hq1001.096651","article-title":"Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice","volume":"21","author":"van de Poll","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.208595_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.ATV.0000148866.29829.19","article-title":"Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice","volume":"25","author":"Verschuren","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.208595_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/FPC.0b013e328359d274","article-title":"Systems biology analysis unravels the complementary action of combined rosuvastatin and ezetimibe therapy","volume":"22","author":"Verschuren","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.113.208595_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(01)00678-5","article-title":"Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E","volume":"162","author":"Wang","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.113.208595_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/jpet.113.208595_bib33","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.208595_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1365\/s10337-007-0395-3","article-title":"HPLC determiniation of lovastatin in rat tissue","volume":"66","author":"Zhang","year":"2007","journal-title":"Chromatographia"},{"key":"10.1124\/jpet.113.208595_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.110.037861","article-title":"Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse","volume":"39","author":"Zhu","year":"2011","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524288388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524288388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.208595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:20:37Z","timestamp":1739996437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524288388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022356524288388"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.208595","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.208595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}